Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01968967 · ClinicalTrials.gov registry record · Phase 3
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
A Phase 3 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 3
- Development phase
- 2,139
- Enrollment target
NCT01968967: Completed Phase 3 study, sponsored by Pfizer.
NCT01968967 is a Phase 3 study that has completed, run by Pfizer. The registered enrollment target is 2,139 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (177% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01968967, a Phase 3 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 2,139 participants
- Enrollment target
Study Summary
This study is a multicenter, randomized study in subjects with high cholesterol receiving highly effective statins to assess the efficacy, safety and tolerability of Bococizumab (PF-04950615;RN316) to lower LDL-C.
Interventions
- OTHER Placebo
- DRUG Bococizumab (PF-04950615; RN316)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,139 participants |
| Start Date | 2013-10-29 |
| Est. Completion | 2017-07-10 |
| Phase | Phase 3 |
What the finished NCT01968967 record still lists
NCT01968967 is an interventional study that assigns participants to a tested intervention. Its 2,139 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (177% higher).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01968967 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01968967 about?
NCT01968967 is a clinical study titled "Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events". This study is a multicenter, randomized study in subjects with high cholesterol receiving highly effective statins to assess the efficacy, safety and tolerability of Bococizumab (PF-04950615;RN316) to lower LDL-C.
What is the current status of trial NCT01968967?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 2,139 participants. The study started on 2013-10-29. Estimated completion is 2017-07-10.
What interventions are being tested in trial NCT01968967?
The interventions under investigation include: Placebo (OTHER), Bococizumab (PF-04950615; RN316) (DRUG).
Who is sponsoring clinical trial NCT01968967?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01968967's enrollment target sits among peer trials
2,139 97th of 2000 higher than 1,904 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03488693 · 2,140 participants · Phase 3
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
- NCT06598475 · 2,142 participants · NA
Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a Adolescents
- NCT05650658 · 2,136 participants · NA
Left vs Left Randomized Clinical Trial
- NCT05805709 · 2,145 participants · NA
A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI